Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. (STXS) on August 29, 2025. The filing discloses the entry into a Material Definitive Agreement regarding a new equity financing arrangement.
Key Financial Metrics and Transaction Details
The filing does not report revenue, profit, cash flow, margins, or existing debt levels. The primary financial metric disclosed relates to the new financing facility:
- Maximum Offering Size: Up to $50,000,000 in aggregate sales price of common stock.
- Underwriter: Roth Capital Partners, LLC.
- Placement Fee: Up to 3.0% of the gross sales price of shares sold.
- Expense Reimbursement: Up to $50,000 for legal fees and up to $5,000 per calendar quarter for ongoing disbursements during active sales periods.
Material Changes and Transaction Structure
The Company entered into a Sales Agreement allowing for "at-the-market" offerings or privately negotiated transactions. Key structural details include:
- Registration Basis: Sales will be made under an effective "shelf" registration statement (Form S-3) filed on June 6, 2023, which covers up to $100,000,000 in securities.
- Role of Agent: Roth Capital may act as a sales agent or as a principal (buying shares for its own account), though they are not obligated to purchase as a principal without a separate agreement.
- Flexibility: The Company or Roth Capital may suspend the offering under certain circumstances. The Company is not obligated to sell any shares.
Use of Proceeds and Outlook
Management intends to use the net proceeds from the sale of shares for:
- Working capital.
- Research and development.
- General corporate purposes.
- Accelerated commercialization of the innovation pipeline.
The filing does not provide specific financial guidance, risk factors beyond standard legal disclaimers, or details on unusual items. The offering will terminate upon the sale of the aggregate amount specified or if terminated by either party.
Investor Verification Checklist
- Verify the current market price of STXS common stock to assess potential dilution from future sales under the $50 million cap.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific termination rights and pricing limitations.
- Monitor future filings to determine if and when the Company elects to sell shares under this agreement.
- Check the Company's most recent 10-Q or 10-K for current cash balances and liquidity status, as this 8-K does not provide those figures.